| Literature DB >> 30537872 |
Junho Ahn1,2,3, Katherine M Raspovic1,2,3, George T Liu1,2,3, Lawrence A Lavery1,2,3, Javier La Fontaine1,2,3, Paul A Nakonezny1,2,3, Dane K Wukich1,2,3.
Abstract
Chronic kidney disease (CKD) is a major concern in patients with foot disease because it is associated with high rates of neuropathy, peripheral vascular disease, and poor wound healing. The purpose of this study was to evaluate renal dysfunction as a risk factor for reamputation after initial transmetatarsal amputation (TMA). Patients who underwent a TMA were retrospectively identified in the American College of Surgeons National Surgical Quality Improvement Program database. Of 2018 patients, reamputation after TMA occurred in 4.4%. End-stage renal disease (ESRD) was associated with 100% increased odds of TMA failure (adjusted odds ratio [OR] = 2.00; 95% CI = 1.10, 3.52), 128% increased odds of major amputation (adjusted OR = 2.28; 95% CI = 1.27, 3.96), and 182% increased odds of 30-day mortality (adjusted OR = 2.82; 95% CI = 1.69, 4.64). In addition, white blood cell count >10 000/mm3 and deep infection at the time of surgery were independently associated with TMA failure. In conclusion, severe renal dysfunction is associated with TMA failure in the short-term, perioperative period. There was no incremental increase in risk of TMA failure with worsening level of renal function before ESRD. A multidisciplinary approach should be implemented in patients with CKD to prevent foot-related pathologies that may necessitate lower-extremity amputation. Levels of Evidence: Level III: Retrospective cohort study.Entities:
Keywords: nephropathy; outcomes; reamputation; transmetatarsal amputation
Mesh:
Year: 2018 PMID: 30537872 DOI: 10.1177/1938640018816371
Source DB: PubMed Journal: Foot Ankle Spec ISSN: 1938-6400